Much of the AD research over the years has focused on attempts to better understand the BACE1-γ-secretase-mediated amyloidogenic pathway, as well as searching for means to inhibit APP proteolysis or to decrease amyloid load. This evidence concerns the gene APP and Alzheimer disease.